Diluted EPS came in at $-0.71 (-39.2% YoY), missed the $-0.67 consensus by $0.04.
Trailing eight quarters through Q1 2025
Common questions about Cabaletta Bio, Inc.'s Q1 2025 earnings report.
Cabaletta Bio, Inc. (CABA) reported Q1 2025 earnings on May 15, 2025 before market open.
Cabaletta Bio, Inc. reported diluted EPS of $-0.71 for Q1 2025.
EPS missed the consensus estimate of $-0.67 by $0.04.
Compared to the same quarter a year prior, diluted EPS declined 39.2% from $-0.51.
You can read the 10-K periodic report (0000950170-25-047201) directly on SEC EDGAR. The filing index links above go to sec.gov.